These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 10387389

  • 1. Celecoxib: a COX-2 inhibitor.
    Andrews SA, Wallace CK, Davis RL.
    Am J Manag Care; 1999 Apr; 5(4):511-8; quiz 522-4. PubMed ID: 10387389
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Celecoxib for the treatment of pain and inflammation: the preclinical and clinical results.
    Tindall E.
    J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S13-7. PubMed ID: 10643176
    [Abstract] [Full Text] [Related]

  • 9. An update on specific COX-2 inhibitors: the COXIBs.
    Gupta S, Crofford LJ.
    Bull Rheum Dis; 2001 Nov; 50(1):1-4. PubMed ID: 12092091
    [No Abstract] [Full Text] [Related]

  • 10. COX-2 inhibitors. Magic bullets or merely mortal?
    Harv Health Lett; 2000 Feb; 25(4):4. PubMed ID: 10637015
    [No Abstract] [Full Text] [Related]

  • 11. COX-2 inhibitors.
    Crowther CL.
    Lippincotts Prim Care Pract; 1999 Feb; 3(4):394-6. PubMed ID: 10624270
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of the baseline cardiovascular risk profile among hypertensive patients prescribed COX-2-specific inhibitors or nonspecific NSAIDs: data from real-life practice.
    Zhao SZ, Burke TA, Whelton A, von Allmen H, Henderson SC.
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S392-400. PubMed ID: 12416789
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Tolerable pain therapy in rheumatism saves long-term costs. Despite this most COX-2 candidates receive conventional NSAID therapy].
    MMW Fortschr Med; 2003 Jul 24; 145(29-30):61. PubMed ID: 12958786
    [No Abstract] [Full Text] [Related]

  • 17. Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?
    Jüni P, Rutjes AW, Dieppe PA.
    BMJ; 2002 Jun 01; 324(7349):1287-8. PubMed ID: 12039807
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [The cardiovascular safety of cyclooxygenase-2 (COX-2) inhibitors].
    Hasdai D, Gottlieb S, Godbourt U, Hod H, Kaluski E.
    Harefuah; 2002 Oct 01; 141(10):922-4. PubMed ID: 12420602
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.